Roland Tomasi1, David Betz2, Sophie Schlager2, Tobias Kammerer2, Dominik J Hoechter2, Thomas Weig2, Peter Slinger3, Laura V Klotz4, Bernhard Zwißler2, Nandor Marczin5, Vera von Dossow2. 1. Department of Anesthesiology, Ludwig-Maximilians-University of Munich, Munich, Germany. Electronic address: roland.tomasi@med.uni-muenchen.de. 2. Department of Anesthesiology, Ludwig-Maximilians-University of Munich, Munich, Germany. 3. Department of Anesthesia, Toronto General Hospital, University of Toronto, Toronto, Canada. 4. Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich/ Asklepios Fachkliniken Gauting, Munich, Germany; Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany. 5. Department of Cardiothoracic Transplantation & Mechanical Support Anaesthetics, Pain Medicine and Intensive Care, Imperial College London and Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom; Department of Anaesthesia and Intensive Therapy, Semmelweis University, Budapest, Hungary.
Abstract
OBJECTIVE: Although increasing evidence in lung transplantation (LTx) suggests that intraoperative management could influence outcomes, there are no guidelines available regarding intraoperative management of LTx. The overall goal of the study was to assess geographic and center volume-specific clinical practices in perioperative management. DESIGN: Prospective data analysis. SETTING: Online survey from a single-center university hospital. PARTICIPANTS: European and non-European LTx centers. INTERVENTIONS: An online survey was sent to 176 centers currently performing LTx procedures. It covered organizational data, general anesthesia considerations, fluid therapy and coagulation, antioxidant and anti-inflammatory therapies, and ventilation strategies. MEASUREMENTS AND MAIN RESULTS: The response rates were 57.5% (n = 42) from European and 32% (n = 33) from non-European countries. Significant differences between European and non-European countries were use of volatile hypnotics (p = 0.016), use of sufentanil (p < 0.001), inotropic agents (p = 0.001) and colloid infusion (p < 0.001), use of calibrated pulse contour analysis (p = 0.004), use of intraoperative traditional laboratory-based coagulation tests (p = 0.001) and platelet function analysis (p = 0.005), and use of higher peak inspiratory pressure (p = 0.009). Center volume-specific differences were use of fentanyl (p = 0.03) and the use of higher peak inspiratory pressure (p = 0.005) for ventilation. Induction of anesthesia and use of advanced hemodynamic monitoring, therapy for pulmonary hypertension, antioxidant and anti-inflammatory therapies, and ventilation strategies were not different among the centers. CONCLUSIONS: This survey demonstrated for the first time statistically significant differences among European and non-European centers and among low- versus high-volume centers regarding intraoperative management during LTx. These observations will be of some guidance for the LTx community and may trigger more extensive studies.
OBJECTIVE: Although increasing evidence in lung transplantation (LTx) suggests that intraoperative management could influence outcomes, there are no guidelines available regarding intraoperative management of LTx. The overall goal of the study was to assess geographic and center volume-specific clinical practices in perioperative management. DESIGN: Prospective data analysis. SETTING: Online survey from a single-center university hospital. PARTICIPANTS: European and non-European LTx centers. INTERVENTIONS: An online survey was sent to 176 centers currently performing LTx procedures. It covered organizational data, general anesthesia considerations, fluid therapy and coagulation, antioxidant and anti-inflammatory therapies, and ventilation strategies. MEASUREMENTS AND MAIN RESULTS: The response rates were 57.5% (n = 42) from European and 32% (n = 33) from non-European countries. Significant differences between European and non-European countries were use of volatile hypnotics (p = 0.016), use of sufentanil (p < 0.001), inotropic agents (p = 0.001) and colloid infusion (p < 0.001), use of calibrated pulse contour analysis (p = 0.004), use of intraoperative traditional laboratory-based coagulation tests (p = 0.001) and platelet function analysis (p = 0.005), and use of higher peak inspiratory pressure (p = 0.009). Center volume-specific differences were use of fentanyl (p = 0.03) and the use of higher peak inspiratory pressure (p = 0.005) for ventilation. Induction of anesthesia and use of advanced hemodynamic monitoring, therapy for pulmonary hypertension, antioxidant and anti-inflammatory therapies, and ventilation strategies were not different among the centers. CONCLUSIONS: This survey demonstrated for the first time statistically significant differences among European and non-European centers and among low- versus high-volume centers regarding intraoperative management during LTx. These observations will be of some guidance for the LTx community and may trigger more extensive studies.
Authors: Andrew W Murray; Michael L Boisen; Ashley Fritz; J Ross Renew; Archer Kilbourne Martin Journal: J Thorac Dis Date: 2021-11 Impact factor: 2.895
Authors: Roland Tomasi; Mathias Klemm; Christian Ludwig Hinske; Nikolai Hulde; René Schramm; Bernhard Zwißler; Vera von Dossow Journal: J Clin Psychol Med Settings Date: 2021-05-19